Helen Louise Collins
CIK 1701247 · CHIEF MEDICAL OFFICER · last filed 2026-06-04
Helen Louise Collins is a CHIEF MEDICAL OFFICER who has filed 45 SEC Form 4 insider transactions across 5 companies since 2017. The most recent filing, for KURA, was dated Jun 4, 2026. Across all open-market trades the lifetime net is −$4.9M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $510.6K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$510.6K
5
45
-$4.89M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| KURA | Director | — | $9.05 | — | $0 | 6 | 2026-06-04 |
| IMRA | CHIEF MEDICAL OFFICER | 30,000 | $17.02 | $510.6K | -$4.89M | 13 | 2026-05-20 |
| IO Biotech, Inc. (IOBT) Delisted | Director | — | $0.05 | — | $0 | 3 | 2025-06-06 |
| FIVE PRIME THERAPEUTICS, INC. (FPRX) Delisted | EVP and Chief Medical Officer | 69,547 | $38.00 | $2.64M | $0 | 9 | 2021-04-19 |
| FIVE PRIME THERAPEUTICS, INC. (XLRN) Delisted | EVP and Chief Medical Officer | 44,298 | $178.75 | $7.92M | $0 | 14 | 2019-09-04 |
Recent Filings
45 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-04 | KURA | Grant (A) | — | $0 | EDGAR |
| 2026-05-20 | IMRA | Mixed | — | -$186.6K | EDGAR |
| 2026-04-21 | IMRA | Mixed | — | -$226.0K | EDGAR |
| 2026-03-27 | IMRA | Mixed | — | -$1.30M | EDGAR |
| 2026-03-19 | IMRA | Mixed | — | -$126.4K | EDGAR |
| 2026-03-11 | IMRA | Mixed | — | -$1.10M | EDGAR |
| 2026-02-19 | IMRA | Mixed | — | -$1.07M | EDGAR |
| 2026-02-17 | IMRA | Grant (A) | +25,000 | $0 | EDGAR |
| 2025-06-06 | KURA | Grant (A) | — | $0 | EDGAR |
| 2025-06-06 | IO Biotech, Inc. (IOBT) Delisted | Grant (A) | — | $0 | EDGAR |